Patient Preferences Influencing Treatment Decision-Making in Early-Stage Breast Cancer in Germany, Italy, and Japan

Autor: Flood E, McCutcheon S, Beusterien K, Mackie DS, Mokiou S, Guillaume X, Mulvihill E

Publikováno v: Patient Preference and Adherence, Vol Volume 18, Pp 1517-1530 (2024)

Emuella Flood,1 Susan McCutcheon,2 Kathleen Beusterien,3 deMauri S Mackie,3 Stella Mokiou,1 Xavier Guillaume,3 Emily Mulvihill3 1Patient Centered Science, AstraZeneca, Gaithersburg, MD, USA; 2Global Medical Affairs, AstraZeneca, Cambridge, UK; 3Healt

Externí odkaz: https://doaj.org/article/ab49d531bf594761824f298b401fa11d

P262 How patients prioritize features of different potential treatment pathways in early breast cancer: a best-worst scaling study

Autor: Jackisch, C., Mulvihill, E., Flood, E., McCutcheon, S., Mackie, D.S., Guillaume, X., Will, O., Beusterien, K., Shimizu, C., Mokiou, S.

Publikováno v: In The Breast April 2023 68 Supplement:S119-S120

Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a CancerLinQ® study.

Autor: Miller RS; CancerLinQ®, American Society of Clinical Oncology, 2318 Mill Road #800, Alexandria, VA, 22314, USA. Robert.miller@asco.org., Mokiou S; AstraZeneca, Cambridge, UK., Taylor A; AstraZeneca, Cambridge, UK., Sun P; AstraZeneca, Cambridge, UK., Baria K; AstraZeneca Pharmaceuticals LP, Gaithersburg, MD, USA.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 May; Vol. 193 (1), pp. 83-94. Date of Electronic Publication: 2022 Feb 22.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Rationale and study protocol of ACQUIRE, a prospective, observational study measuring quality of life, treatment preference and treatment satisfaction of autosomal dominant polycystic kidney disease (ADPKD) patients in Europe.

Autor: Joly D; Nephrology Department, Necker Hospital, 149 Rue de Sèvres, 75015, Paris, France. dominique.joly@nck.aphp.fr., Quinn J; BioMarin Pharmaceutical Inc., London, UK., Mokiou S; Otsuka Pharmaceutical Europe Ltd., Wexham, UK., O'Reilly K; Otsuka Pharmaceutical Europe Ltd., Wexham, UK., Sánchez-Covisa J; Otsuka Pharmaceutical Europe Ltd., Wexham, UK., Wang-Silvanto J; Otsuka Pharmaceutical Europe Ltd., Wexham, UK., Doll H; Clinical Outcomes Solutions, Folkestone, UK.

Publikováno v: BMC nephrology [BMC Nephrol] 2020 Jul 24; Vol. 21 (1), pp. 298. Date of Electronic Publication: 2020 Jul 24.